Skip to content
10-Q

Quarterly Report

FRESH TRACKS THERAPEUTICS, INC.

0000819050-23-000064

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 3, 2023 5.91M sh
Shares Diluted Q2 2023 · Jun 30, 2023 5.91M sh
Shares Diluted Q2 2023 · Jun 30, 2023 4.84M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$6.3M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $8.95M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $8.68M
Stockholders Equity Q2 2023 · Jun 30, 2023 $7.99M
Stockholders Equity Q2 2023 · Mar 31, 2023 $9.87M
Stockholders Equity Q2 2023 · Dec 31, 2022 $7.19M
Current Liabilities Q2 2023 · Jun 30, 2023 $1.85M
Current Liabilities Q2 2023 · Dec 31, 2022 $3.08M
Current Assets Q2 2023 · Jun 30, 2023 $9.71M
Current Assets Q2 2023 · Dec 31, 2022 $10.08M
Total Assets Q2 2023 · Jun 30, 2023 $9.84M
Total Assets Q2 2023 · Dec 31, 2022 $10.27M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.39
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.36
Eps Basic Q2 2023 · Jun 30, 2023 −$0.39
Eps Basic Q2 2023 · Jun 30, 2023 −$1.36
Sga Expense Q2 2023 · Jun 30, 2023 $1.81M
Sga Expense Q2 2023 · Jun 30, 2023 $4.22M
Rd Expense Q2 2023 · Jun 30, 2023 $609K
Rd Expense Q2 2023 · Jun 30, 2023 $2.55M
Net Income Q2 2023 · Jun 30, 2023 −$2.28M
Net Income Q2 2023 · Jun 30, 2023 −$6.56M
Net Income Q2 2023 · Mar 31, 2023 −$4.28M
Operating Income Q2 2023 · Jun 30, 2023 −$2.36M
Operating Income Q2 2023 · Jun 30, 2023 −$6.71M
Revenue Q2 2023 · Jun 30, 2023 $53K
Revenue Q2 2023 · Jun 30, 2023 $62K